Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2872-2880

  Veltman, Joris A ^c   Fridlyand, Jane ^a   Pejavar, Sunanda ^a   Olshen, Adam B ^a,d   Korkola, James E ^a   DeVries, Sandy ^a   Carroll, Peter ^a   Kuo, Wen Lin ^a   Pinkel, Daniel ^b   Albertson, Donna ^b   Cordon Cardo, Carlos ^d   Jain, Ajay N ^b   Waldman, Frederic M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER STAGING; COMPARATIVE GENOMIC HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE MAPPING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

CHROMOSOMES, HUMAN, PAIR 9; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; STATISTICS; URINARY BLADDER NEOPLASMS;

EID: 0037905690     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B. M., Gray, J. W., and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.
2. Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., Law, S., Myambo, K., Palmer, J., Ylstra, B., Yue, J. P., Gray, J. W., Jain, A. N., Pinkel, D., and Albertson, D. G. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet., 29: 263-264, 2001.
3. Albertson, D. G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S. H., Kowbel, D., Kuo, W. L., Gray, J. W., and Pinkel, D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet., 25: 144-146, 2000.
4. Wilhelm, M., Veltman, J. A., Olshen, A. B., Jain, A. N., Moore, D. H., Presti, J. C., Jr., Kovacs, G., and Waldman, F. M. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res., 62: 957-960, 2002.
5. Li, B., Kanamaru, H., Noriki, S., Fukuda, M., and Okada, K. Numeric aberration of chromosome 17 is strongly correlated with p53 overexpression, tumor proliferation and histopathology in human bladder cancer. Int. J. Urol., 5: 317-323, 1998.
6. Li, M., Zhang, Z. F., Reuter, V. E., and Cordon-Cardo, C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am. J. Pathol., 149: 229-235, 1996.
7. l papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57: 2860-2864, 1997.
8. Wagner, U., Bubendorf, L., Gasser, T. C., Moch, H., Gorog, J. P., Richter, J., Mihatsch, M. J., Waldman, F. M., and Sauter, G. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am. J. Pathol., 151: 753-759, 1997.
9. Simon, R., Burger, H., Brinkschmidt, C., Bocker, W., Hertle, L., and Terpe, H. J. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J. Pathol., 185: 345-351, 1998.
10. Simoneau, A. R., and Jones, P. A. Bladder cancer: the molecular progression to invasive disease. World J. Urol., 12: 89-95, 1994.
11. Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Nowak, N., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., and Gray, J. W. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet., 29: 459-464, 2001.
12. Olshen, A. B., and Jain, A. N. Deriving quantitative conclusions from microarray expression data. Bioinformatics, 18: 961-970, 2002.
13. Jain, A. N., Chin, K., Borresen-Dale, A. L., Erikstein, B. K., Eynstein, L. P., Kaaresen, R., and Gray, J. W. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl. Acad. Sci. USA, 98: 7952-7957, 2001.
14. Richter, J., Beffa, L., Wagner, U., Schraml, P., Gasser, T. C., Moch, H., Mihatsch, M. J., and Sauter, G. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am. J. Pathol., 153: 1615-1621, 1998.
15. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell. Biol., 2: 731-737, 2001.
16. Humbert, P. O., Verona, R., Trimarchi, J. M., Rogers, C., Dandapani, S., and Lees, J. A. E2f3 is critical for normal cellular proliferation. Genes Dev., 14: 690-703, 2000.
17. Wu, L., Timmers, C., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P., Wright, F. A., Field, S. J., Greenberg, M. E., Orkin, S., Nevins, J. R., Robinson, M. L., and Leone, G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature (Lond.), 414: 457-462, 2001.
18. Ziebold, U., Reza, T., Caron, A., and Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev., 15: 386-391, 2001.
19. Rabbani, F., Richon, V. M., Orlow, I., Lu, M. L., Drobnjak, M., Dudas, M., Charytonowicz, E., Dalbagni, G., and Cordon-Cardo, C. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J. Natl. Cancer Inst., (Bethesda) 91: 874-881, 1999.
20. Goldfarb, M. Signaling by fibroblast growth factors: the inside story. Sci. STKE, 2001: E37, 2001.
21. Simon, R., Richter, J., Wagner, U., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Wilber, K., Anabitarte, M., Hering, F., Hardmeier, T., Schonenberger, A., Flury, R., Jager, P., Fehr, J. L., Schraml, P., Moch, H., Mihatsch, M. J., Gasser, T., and Sauter, G. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res., 61: 4514-4519, 2001.
22. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev., 12: 2245-2262, 1998.
23. Nevins, J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ., 9: 585-593, 1998.
24. Wada, T., Louhelainen, J., Hemminki, K., Adolfsson, J., Wijkstrom, H., Norming, U., Borgstrom, E., Hansson, J., Sandstedt, B., and Steineck, G. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Clin. Cancer Res., 6: 610-615, 2000.
25. Sgambato, A., Migaldi, M., Faraglia, B., De Aloysio, G., Ferrari, P., Ardito, R., De Gaetani, C., Capelli, G., Cittadini, A., and Trentini, G. P. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycleassociated proteins, cell proliferation and clinical outcome. Int. J. Cancer. 97: 671-678, 2002.
26. Richter, J., Wagner, U., Kononen, J., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R., Alund, G., Knonagel, H., Rist, M., Wilber, K., Anabitarte, M., Hering, F., Hardmeier, T., Schonenberger, A., Flury, R., Jager, P., Fehr, J. L., Schraml, P., Moch, H., Mihatsch, M. J., Gasser, T., Kallioniemi, O. P., and Sauter, G. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am. J. Pathol., 157: 787-794, 2000.
27. Rabbani, F., and Cordon-Cardo, C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. Urol. Clin. North Am., 27: 83-102, ix, 2000.
28. Geng, Y., Whoriskey, W., Park, M. Y., Bronson, R. T., Medema, R. H., Li, T., Weinberg, R. A., and Sicinski, P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell, 97: 767-777, 1999.
29. Jaeger, T. M., Weidner, N., Chew, K., Moore, D. H. Kerschmann, R. L., Waldman, F. M., and Carroll, P. R. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J. Urol., 154: 69-71, 1995.
30. Kallioniemi, A., Kallioniemi, O. P., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Caroll, P., and Waldman, F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12: 213-219, 1995.